Zymenex was founded in 1998 by Jens Fogh and Pär Gellerfors. Zymenex currently employs a total of 18 people.
Zymenex has its headquarters in the prestigious Medicon Valley in Hillerød, north of Copenhagen, and R&D facilities on Lidingö in Stockholm.
All administrative functions including regulatory and medical affairs, quality assurance and project management are located in Hillerød.
The R&D laboratory on Lidingö does the initial product development. This includes characterization of the expressed clones, development of methods of analysis and development of new product concepts and technologies.
Zymenex does not operate its own production facilities. The company has outsourced the manufacturing of pre-clinical and clinical material to contract manufacturers in Sweden, Denmark and Germany.